The 2025 to 2030 Dietary Guidelines for Americans were released in early January, and the alcohol section is now two sentences long. Where previous editions specified no more than two drinks a day for men and one for women, the new edition advises drinking less alcohol for better overall health and limiting intake, without naming a number. The references to alcohol as a cancer risk factor are gone as well.

Within days the American Association for the Study of Liver Diseases published a formal objection, and The Lancet Gastroenterology and Hepatology ran an editorial calling the change a step backwards. The specific complaint is not that the guidelines got the science wrong. It is that they stopped saying what the science says.

From the Lab to the Ledger

The guidelines are updated every five years and carry weight beyond advice. They set the nutritional standards for school meals, military food service and federal nutrition programs, and they are the reference clinicians and dietitians reach for when a patient asks what is reasonable. A number in that document becomes the default answer to a question millions of people ask their doctor.

Removing the number does not remove the underlying evidence, which has moved in one direction over the past decade. Alcohol is classified as a Group 1 carcinogen, the same category as tobacco and asbestos, a classification based on the strength of the evidence that it causes cancer rather than on how much risk any given drink carries. Consumption is associated with at least seven cancer types, including breast, colorectal, liver, esophageal and head and neck cancers. Much of the apparent protective effect of moderate drinking on heart disease, the finding that supported the old daily allowances, has held up poorly under methods that account for the fact that people who quit drinking because they are already ill get counted as abstainers.

That is what makes the change awkward to interpret. Two defensible positions exist. One is that the old numbers implied a precision the evidence does not support, and that a directional statement is more honest. The other is that vague guidance is not neutral: in the absence of a threshold, most people substitute their own, and the public loses the one piece of information they would use. The liver and gastroenterology societies take the second position, and they have also pointed out that the guidelines say nothing about biological sex differences in alcohol metabolism, which are substantial and well documented.

The practical effect is a shift in where this decision gets made. A guideline number does a great deal of work on its own, in clinics and in kitchens, without anyone having to look up a study. Removing it moves the question to individual clinicians and individual readers, and to whatever they happen to know.

Bio-Pipeline Ledger

Alcohol as an established carcinogen: settled classification, based on decades of epidemiology across multiple cancer sites. Not in dispute, and not mentioned in the new guidelines.

Alcohol and liver disease: well established across the full range from fatty liver to cirrhosis, with rates of alcohol-associated liver disease rising in younger adults over the past decade.

The cardiovascular benefit of moderate drinking: substantially weakened by newer analyses that correct for sick-quitter bias and by genetic studies. Once the basis for the daily allowances, now the least secure part of the picture.

Biological sex differences in alcohol metabolism: well documented, with women reaching higher blood alcohol levels at the same intake and showing liver injury at lower cumulative exposure. Addressed in the previous guidelines and absent from the current ones.

Federal dietary guidance as an input to clinical practice and institutional food policy: real and mechanical. These documents set school meal standards and program rules, not just recommendations.

Individual risk tolerance in the absence of a stated threshold: unavoidable now, and the reason clinicians objected.

The Clinical Reality Check

What is established is that the evidence linking alcohol to cancer and liver disease has strengthened, not weakened, over the period in which the guidance grew vaguer. Nothing published between the two editions supports loosening the message.

What is overstated is any reading of this as official permission. A guideline that says drink less is not a guideline that says drinking more is fine, and the removal of a number is not a finding. Anyone marketing it that way is selling something.

The useful version for a reader is that the old thresholds remain a reasonable reference point, because the evidence behind them did not change in January. If you want a number, most clinicians will still tell you what the previous edition said and why. If your intake is at a level you would rather not say out loud to a physician, that is worth a conversation regardless of what any document specifies, and it is one of the few health discussions where an honest answer changes the advice immediately.